Elizabeth Joubert Selected Research

Xanthones

4/2021	Physicochemical Stability of Enriched Phenolic Fractions of Cyclopia genistoides and ex vivo Bi-directional Permeability of Major Xanthones and Benzophenones.
11/2019	Potential of benzophenones and flavanones to modulate the bitter intensity of Cyclopia genistoides herbal tea.
10/2017	Thermal stability of the functional ingredients, glucosylated benzophenones and xanthones of honeybush (Cyclopia genistoides), in an aqueous model solution.
10/2016	Anti-Inflammatory Effects of Aspalathus linearis and Cyclopia spp. Extracts in a UVB/Keratinocyte (HaCaT) Model Utilising Interleukin-1α Accumulation as Biomarker.
6/2015	Thermal Degradation Kinetics Modeling of Benzophenones and Xanthones during High-Temperature Oxidation of Cyclopia genistoides (L.) Vent. Plant Material.
10/2014	Chemometric analysis of chromatographic fingerprints shows potential of Cyclopia maculata (Andrews) Kies for production of standardized extracts with high xanthone content.
1/2011	Modulating effects of rooibos and honeybush herbal teas on the development of esophageal papillomas in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elizabeth Joubert Research Topics

Disease

45	cyclopia sequence 07/2021 - 06/2003
8	Hyperglycemia 10/2022 - 10/2014
6	Body Weight (Weight, Body) 01/2021 - 10/2008
6	Obesity 04/2020 - 03/2013
5	Insulin Resistance 12/2021 - 11/2015
4	Neoplasms (Cancer) 01/2021 - 01/2009
3	Type 2 Diabetes Mellitus (MODY) 12/2021 - 04/2020
3	Inflammation (Inflammations) 12/2021 - 10/2016
3	Metabolic Diseases (Metabolic Disease) 01/2020 - 01/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 10/2016
3	Carcinogenesis 10/2016 - 06/2005
2	Prostatic Neoplasms (Prostate Cancer) 04/2020 - 11/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2018 - 01/2018
2	Dehydration (Water Stress) 06/2018 - 10/2010
1	Dysbiosis 12/2021
1	Hyperuricemia 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Hypercholesterolemia 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Neuroblastoma 01/2020
1	Heart Diseases (Heart Disease) 01/2017
1	Skin Neoplasms (Skin Cancer) 10/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2014
1	Papilloma (Papillomatosis) 01/2011

Drug/Important Bio-Agent (IBA)

22	Herbal TeasIBA 01/2021 - 06/2003
15	TeaIBA 01/2021 - 06/2003
14	aspalathinIBA 12/2021 - 10/2008
13	PolyphenolsIBA 07/2021 - 06/2003
7	xanthoneIBA 04/2021 - 07/2006
7	XanthonesIBA 04/2021 - 01/2011
7	AntioxidantsIBA 07/2018 - 02/2008
6	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2016
6	FlavonoidsIBA 01/2021 - 01/2011
6	mangiferinIBA 11/2019 - 07/2006
4	GlucosidasesIBA 10/2022 - 12/2014
4	dihydrochalconeIBA 12/2021 - 01/2018
4	benzophenoneIBA 04/2021 - 03/2014
4	BenzophenonesIBA 04/2021 - 06/2015
4	isomangiferinIBA 11/2019 - 05/2009
3	Food IngredientsIBA 07/2020 - 12/2012
3	PalmitatesIBA 02/2019 - 11/2015
3	AcidsIBA 01/2018 - 10/2010
3	Methanol (Carbinol)IBA 11/2016 - 05/2007
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2022 - 12/2021
2	Acarbose FDA LinkGeneric 10/2022 - 07/2020
2	flavoneIBA 12/2021 - 08/2014
2	Citric Acid (Citrate)FDA LinkGeneric 07/2021 - 06/2018
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 07/2021 - 10/2010
2	Pharmaceutical PreparationsIBA 04/2020 - 12/2003
2	Biological ProductsIBA 12/2019 - 01/2019
2	Protein Kinases (Protein Kinase)IBA 02/2019 - 01/2019
2	Phosphotransferases (Kinase)IBA 02/2019 - 01/2019
2	LipidsIBA 02/2019 - 01/2018
2	Insulin (Novolin)FDA Link 02/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2014
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 06/2018
2	GlycosidesIBA 12/2018 - 02/2008
2	GlucosidesIBA 01/2018 - 12/2014
2	IronIBA 11/2016 - 10/2016
1	PhytochemicalsIBA 12/2021
1	PhlorhizinIBA 12/2021
1	oxidized low density lipoproteinIBA 08/2021
1	CholesterolIBA 08/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	homoorientin (isoorientin)IBA 01/2020
1	FlavanonesIBA 11/2019
1	AndrogensIBA 11/2019
1	SteamIBA 02/2019
1	AMP-Activated Protein KinasesIBA 02/2019
1	Aligeron (AS 2)IBA 12/2018
1	naringeninIBA 12/2018
1	PowdersIBA 06/2018
1	Sweetening Agents (Sweeteners)IBA 06/2018
1	Anti-Allergic Agents (Antiallergic Agents)IBA 03/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	SolutionsIBA 10/2017
1	4-sulfophenylmethallyl ether (SPME)IBA 07/2017
1	Metformin (Glucophage)FDA LinkGeneric 11/2016
1	Biomarkers (Surrogate Marker)IBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016
1	Gallic AcidIBA 12/2015
1	Nonesterified Fatty Acids (NEFA)IBA 11/2015
1	FructoseIBA 10/2014
1	maclurinIBA 08/2014
1	iriflophenoneIBA 08/2014
1	flavanoneIBA 08/2014
1	phenolic acidIBA 08/2014
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 08/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	Volatile Organic CompoundsIBA 03/2012
1	nitrosobenzylmethylamineIBA 01/2011
1	proanthocyanidinIBA 01/2011

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2017
2	Castration 04/2020 - 11/2019
1	Drug Tapering 07/2020
1	Immunotherapy 03/2018